
This review article written by Kirk E. Cahill, MD, and Sonali M. Smith, MD, discusses standard and emerging therapies for the treatment of follicular lymphoma.

Your AI-Trained Oncology Knowledge Connection!


This review article written by Kirk E. Cahill, MD, and Sonali M. Smith, MD, discusses standard and emerging therapies for the treatment of follicular lymphoma.

By combining the most recent medical literature and expert opinion, this revised guideline can aid clinicians in the complex decision-making associated with the management of recurrent Hodgkin lymphoma.

Overall, the future of patients with MCL is promising, since therapeutic options have widened. The implementation of universal aggressive treatment is challenged by novel regimens, targeted agents, the use of MRD to guide treatment decisions, and new trials that will directly compare transplant vs non-transplant approaches.

The self-stated mission of Clinical Malignant Hematology is to provide a comprehensive and clinically focused guide to the management of patients with hematologic malignancies.

Published: February 17th 2022 | Updated:

Published: December 1st 2007 | Updated:

Published: April 15th 2016 | Updated:

Published: December 15th 2016 | Updated: